AlphaMaven AlphaMaven

Clearlake and Charlesbank to inject $175m into distressed Symplr

Reported by Privateequitywire
Sep 22, 2026· 2 min read
Save Post LinkedIn Email
Key Takeaways
  • • Clearlake Capital Group and Charlesbank Capital Partners will inject $175 million in preferred equity into distressed healthcare software provider Symplr to stabilize finances and extend debt maturities.
  • • Second-lien lenders will provide an additional $103.5 million through a first-out second-lien loan, ranking ahead of existing second-lien debt and available to junior-ranking creditors.
  • • Symplr's first-lien term loan lenders will receive a 100-basis-point coupon increase in exchange for extending maturity by three years beyond the original 2027 maturity; second-lien lenders receive the same coupon increase with combined cash and payment-in-kind interest structures.
  • • The restructuring follows months of creditor negotiations as Symplr's debt traded at distressed levels, exacerbated by Moody's July downgrade into junk territory and broader sector concerns about artificial intelligence's impact on software valuations.
  • • Clearlake and Charlesbank will defer interest payments on newly issued junior-ranking debt, preserving critical cash for the company during its financial recovery period.
Summary
Private equity sponsors Clearlake Capital Group and Charlesbank Capital Partners have reached an agreement to provide $175 million in preferred equity to Symplr, a healthcare software provider facing significant financial stress. The investment represents a key restructuring initiative designed to reinforce the company's balance sheet while extending maturities on outstanding debt obligations. According to Bloomberg, the sponsors have secured buy-in from multiple creditor groups and are actively seeking broader lender support for the proposed recapitalization.

The financing package reflects a layered capital structure addressing different creditor constituencies. Beyond the $175 million preferred equity injection, second-lien lenders will fund $103.5 million through a first-out second-lien facility that ranks ahead of existing second-lien obligations, providing additional liquidity while preserving covenant flexibility. Notably, Clearlake and Charlesbank will defer interest payments on newly issued junior debt, a critical cash preservation mechanism as Symplr navigates its operational and financial challenges. Both existing second-lien and first-lien term loan holders will receive 100-basis-point coupon increases as compensation for debt modifications—second-lien holders receiving blended cash and payment-in-kind interest, while first-lien holders gain a three-year maturity extension beyond the original 2027 maturity date.

Symplr's distress reflects broader pressures on enterprise software valuations. The company's debt traded at distressed levels for months, with holdings among the largest markdowns in an Ares private credit fund during the first quarter. Moody's Ratings downgraded Symplr into junk territory in July, citing elevated restructuring risk. Market concerns extend beyond company-specific factors to sector-wide uncertainty regarding artificial intelligence adoption and its impact on software provider economics. The protracted negotiations with lenders underscore the complexity of Symplr's financial position and creditors' need for tangible equity participation and incentive structures to support the recapitalization.

Go deeper than the headline

Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.

Start your free 7-day trial

Sources

1 outlet

AlphaMaven summarised this story from the reporting below. Each link opens the original article.

Privateequitywire Clearlake and Charlesbank to inject $175m into distressed Symplr